170 related articles for article (PubMed ID: 27457567)
1. Prognostic value of decreased FOXP1 protein expression in various tumors: a systematic review and meta-analysis.
Xiao J; He B; Zou Y; Chen X; Lu X; Xie M; Li W; He S; You S; Chen Q
Sci Rep; 2016 Jul; 6():30437. PubMed ID: 27457567
[TBL] [Abstract][Full Text] [Related]
2. Forkhead box protein P1 expression in mucosa-associated lymphoid tissue lymphomas predicts poor prognosis and transformation to diffuse large B-cell lymphoma.
Sagaert X; de Paepe P; Libbrecht L; Vanhentenrijk V; Verhoef G; Thomas J; Wlodarska I; De Wolf-Peeters C
J Clin Oncol; 2006 Jun; 24(16):2490-7. PubMed ID: 16636337
[TBL] [Abstract][Full Text] [Related]
3. The Prognostic Value of Forkhead Box P3 Expression in Operable Breast Cancer: A Large-Scale Meta-Analysis.
Lin SC; Gan ZH; Yao Y; Min da L
PLoS One; 2015; 10(8):e0136374. PubMed ID: 26305693
[TBL] [Abstract][Full Text] [Related]
4. Cytoplasmic FOXP1 expression is correlated with ER and calpain II expression and predicts a poor outcome in breast cancer.
Yu BH; Li BZ; Zhou XY; Shi DR; Yang WT
Diagn Pathol; 2018 May; 13(1):36. PubMed ID: 29848352
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Significance of the Metabolic Marker Hexokinase-2 in Various Solid Tumors: A Meta-Analysis.
Liu Y; Wu K; Shi L; Xiang F; Tao K; Wang G
PLoS One; 2016; 11(11):e0166230. PubMed ID: 27824926
[TBL] [Abstract][Full Text] [Related]
6. FOXP1: a potential therapeutic target in cancer.
Koon HB; Ippolito GC; Banham AH; Tucker PW
Expert Opin Ther Targets; 2007 Jul; 11(7):955-65. PubMed ID: 17614763
[TBL] [Abstract][Full Text] [Related]
7. [Expression of FOXP1 and cyclinE in primary central nervous system lymphoma and its significance].
Shen L; Chen BB; Chen Z; Xu XP; Lin GW
Zhonghua Xue Ye Xue Za Zhi; 2012 Aug; 33(8):648-52. PubMed ID: 23134861
[TBL] [Abstract][Full Text] [Related]
8. MALT1, BCL10 and FOXP1 in salivary gland mucosa-associated lymphoid tissue lymphomas.
Borovecki A; Korac P; Ventura RA; Perisa MM; Banham AH; Dominis M
Pathol Int; 2007 Jan; 57(1):47-51. PubMed ID: 17199743
[TBL] [Abstract][Full Text] [Related]
9. Expression of FOXP1 in mucosa-associated lymphoid tissue lymphoma suggests a large tumor cell transformation and predicts a poorer prognosis in the positive thyroid patients.
Jiang W; Li L; Tang Y; Zhang WY; Liu WP; Li GD
Med Oncol; 2012 Dec; 29(5):3352-9. PubMed ID: 22736042
[TBL] [Abstract][Full Text] [Related]
10. The Prognostic Value of Decreased LKB1 in Solid Tumors: A Meta-Analysis.
Xiao J; Zou Y; Chen X; Gao Y; Xie M; Lu X; Li W; He B; He S; You S; Chen Q
PLoS One; 2016; 11(4):e0152674. PubMed ID: 27035914
[TBL] [Abstract][Full Text] [Related]
11. Expression of the forkhead box transcription factor FOXP1 is associated with oestrogen receptor alpha, oestrogen receptor beta and improved survival in familial breast cancers.
Rayoo M; Yan M; Takano EA; Bates GJ; Brown PJ; Banham AH; Fox SB
J Clin Pathol; 2009 Oct; 62(10):896-902. PubMed ID: 19622517
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of MMP Family Members Functions as Prognostic Biomarker for Breast Cancer Patients: A Systematic Review and Meta-Analysis.
Ren F; Tang R; Zhang X; Madushi WM; Luo D; Dang Y; Li Z; Wei K; Chen G
PLoS One; 2015; 10(8):e0135544. PubMed ID: 26270045
[TBL] [Abstract][Full Text] [Related]
13. Bcl-2 but not FOXP1, is an adverse risk factor in immunochemotherapy-treated non-germinal center diffuse large B-cell lymphomas.
Nyman H; Jerkeman M; Karjalainen-Lindsberg ML; Banham AH; Enblad G; Leppä S
Eur J Haematol; 2009 May; 82(5):364-72. PubMed ID: 19141121
[TBL] [Abstract][Full Text] [Related]
14. Both FOXP1 and p65 expression are adverse risk factors in diffuse large B-cell lymphoma: a retrospective study in China.
Hu CR; Wang JH; Wang R; Sun Q; Chen LB
Acta Histochem; 2013 Mar; 115(2):137-43. PubMed ID: 22809882
[TBL] [Abstract][Full Text] [Related]
15. Expression of PIK3CA and FOXP1 in gastric and intestinal non-Hodgkin's lymphoma of mucosa-associated lymphoid tissue type.
Zhai L; Zhao Y; Ye S; Huang H; Tian Y; Wu Q; Lin H; Lin T
Tumour Biol; 2011 Oct; 32(5):913-20. PubMed ID: 21660567
[TBL] [Abstract][Full Text] [Related]
16. Expression of FOXP1 and Colorectal Cancer Prognosis.
De Smedt L; Palmans S; Govaere O; Moisse M; Boeckx B; De Hertogh G; Prenen H; Van Cutsem E; Tejpar S; Tousseyn T; Sagaert X
Lab Med; 2015; 46(4):299-311. PubMed ID: 26489674
[TBL] [Abstract][Full Text] [Related]
17. FOXP1 expression predicts polymorphic histology and poor prognosis in gastric mucosa-associated lymphoid tissue lymphomas.
Han SL; Wu XL; Wan L; Zeng QQ; Li JL; Liu Z
Dig Surg; 2009; 26(2):156-62. PubMed ID: 19365123
[TBL] [Abstract][Full Text] [Related]
18. FOXP1 negatively regulates tumor infiltrating lymphocyte migration in human breast cancer.
De Silva P; Garaud S; Solinas C; de Wind A; Van den Eyden G; Jose V; Gu-Trantien C; Migliori E; Boisson A; Naveaux C; Duvillier H; Craciun L; Larsimont D; Piccart-Gebhart M; Willard-Gallo K
EBioMedicine; 2019 Jan; 39():226-238. PubMed ID: 30579865
[TBL] [Abstract][Full Text] [Related]
19. Expression of the activation markers Blimp1, Foxp1 and pStat3 in extranodal diffuse large B-cell lymphomas.
Petrakis G; Kostopoulos I; Venizelos I; Lambropoulou M; Vouras K; Vakalopoulou S; Mandala E; Tsatalas C; Papadopoulos N
Histol Histopathol; 2017 Aug; 32(8):825-834. PubMed ID: 27924626
[TBL] [Abstract][Full Text] [Related]
20. Expression of the forkhead transcription factor FOXP1 is associated with estrogen receptor alpha and improved survival in primary human breast carcinomas.
Fox SB; Brown P; Han C; Ashe S; Leek RD; Harris AL; Banham AH
Clin Cancer Res; 2004 May; 10(10):3521-7. PubMed ID: 15161711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
